About Cardinal Health (NYSE:CAH)
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Retailers
- Sub-Industry: Health Care Distributors
- Symbol: NYSE:CAH
- CUSIP: 14149Y10
- Web: www.cardinalhealth.com
Capitalization:- Market Cap: $21.11 billion
- Outstanding Shares: 316,453,000
Average Prices:- 50 Day Moving Avg: $67.09
- 200 Day Moving Avg: $72.38
- 52 Week Range: $62.70 - $84.88
P/E:- Trailing P/E Ratio: 16.55
- Foreward P/E Ratio: 12.06
- P/E Growth: 2.07
Sales & Book Value:- Annual Revenue: $129.98 billion
- Price / Sales: 0.16
- Book Value: $21.54 per share
- Price / Book: 3.10
Dividend:- Annual Dividend: $1.85
- Dividend Yield: 2.8%
Profitability:- EBITDA: $3.07 billion
- Net Margins: 0.99%
- Return on Equity: 26.20%
- Return on Assets: 4.81%
Debt:- Debt-to-Equity Ratio: 1.33%
- Current Ratio: 1.34%
- Quick Ratio: 0.80%
Misc:- Average Volume: 2.22 million shs.
- Beta: 0.86
- Short Ratio: 4.82
Frequently Asked Questions for Cardinal Health (NYSE:CAH)
What is Cardinal Health's stock symbol?
Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."
How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?
Cardinal Health announced a quarterly dividend on Wednesday, August 9th. Shareholders of record on Monday, October 2nd will be given a dividend of $0.4624 per share on Sunday, October 15th. This represents a $1.85 dividend on an annualized basis and a yield of 2.77%. The ex-dividend date of this dividend is Friday, September 29th. View Cardinal Health's Dividend History.
How were Cardinal Health's earnings last quarter?
Cardinal Health, Inc. (NYSE:CAH) announced its earnings results on Wednesday, August, 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.24 by $0.07. The business had revenue of $32.97 billion for the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The business's quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.14 earnings per share. View Cardinal Health's Earnings History.
When will Cardinal Health make its next earnings announcement?
What guidance has Cardinal Health issued on next quarter's earnings?
Cardinal Health issued an update on its FY18 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of $5.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.25. Cardinal Health also updated its FY17 guidance to $4.85-5.10 EPS.
Where is Cardinal Health's stock going? Where will Cardinal Health's stock price be in 2017?
12 brokers have issued 1-year price targets for Cardinal Health's shares. Their forecasts range from $72.00 to $82.00. On average, they expect Cardinal Health's share price to reach $76.44 in the next twelve months. View Analyst Ratings for Cardinal Health.
Who are some of Cardinal Health's key competitors?
Some companies that are related to Cardinal Health include Intuitive Surgical (ISRG), Boston Scientific Corporation (BSX), Vertex Pharmaceuticals Incorporated (VRTX), Humana (HUM), Baxter International (BAX), Express Scripts Holding Company (ESRX), Zoetis (ZTS), McKesson Corporation (MCK), Alexion Pharmaceuticals (ALXN), Illumina (ILMN), Fresenius Medical Care Corporation (FMS), Grifols, S.A. (GRFS), HCA Holdings (HCA), Actelion (ALIOF), Astellas Pharma (ALPMY), Essilor International SA (ESLOY), Zimmer Biomet Holdings (ZBH) and Cerner Corporation (CERN).
Who are Cardinal Health's key executives?
Cardinal Health's management team includes the folowing people:
- George S. Barrett, Chairman of the Board, Chief Executive Officer
- Michael C. Kaufmann, Chief Financial Officer
- Donald M. Casey Jr., Chief Executive Officer - Medical Segment
- Jon L. Giacomin, Chief Executive Officer - Pharmaceutical segment
- Pamela O. Kimmet, Chief Human Resource Officer
- Patricia B. Morrison, Executive Vice President - Customer Support Services and Chief Information Officer
- Michele A. M. Holcomb, Executive Vice President, Strategy and Corporate Development
- Craig S. Morford, Chief Legal and Compliance Officer
- Gregory B. Kenny, Lead Independent Director
- David John Anderson, Independent Director
Who owns Cardinal Health stock?
Cardinal Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include PGGM Investments (0.11%), Sit Investment Associates Inc. (0.06%), Shell Asset Management Co. (0.04%), Osborn Williams & Donohoe LLC (0.01%), Shikiar Asset Management Inc. (0.01%) and First United Bank Trust (0.00%). Company insiders that own Cardinal Health stock include Carole S Watkins, Craig S Morford, Donald M Jr Casey, Falk T Stephen, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.
Who sold Cardinal Health stock? Who is selling Cardinal Health stock?
Cardinal Health's stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Sit Investment Associates Inc., Shikiar Asset Management Inc., Eqis Capital Management Inc., Osborn Williams & Donohoe LLC, Meeder Asset Management Inc. and First United Bank Trust. Company insiders that have sold Cardinal Health stock in the last year include George S Barrett and Jon L Giacomin. View Insider Buying and Selling for Cardinal Health.
Who bought Cardinal Health stock? Who is buying Cardinal Health stock?
How do I buy Cardinal Health stock?
Shares of Cardinal Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardinal Health's stock price today?
One share of Cardinal Health stock can currently be purchased for approximately $66.71.
MarketBeat Community Rating for Cardinal Health (NYSE CAH)MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Cardinal Health (NYSE:CAH) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 8 Hold Ratings, 4 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.33) |
| Consensus Price Target: | $76.44 (14.59% upside) |
Consensus Price Target History for Cardinal Health (NYSE:CAH)
Analysts' Ratings History for Cardinal Health (NYSE:CAH)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 10/12/2017 | Needham & Company LLC | Reiterated Rating | Hold | | N/A |  |
| 10/10/2017 | Cowen and Company | Upgrade | Buy | $74.00 | N/A | |
| 9/19/2017 | Royal Bank Of Canada | Initiated Coverage | Sector Perform -> Sector Perform | $72.00 | Low | |
| 9/17/2017 | Robert W. Baird | Reiterated Rating | Hold | $73.00 | Low | |
| 8/29/2017 | Jefferies Group LLC | Set Price Target | Hold | $77.00 | Low | |
| 8/3/2017 | Credit Suisse Group | Lower Price Target | Outperform | $87.00 -> $81.00 | Medium | |
| 7/4/2017 | Evercore ISI | Reiterated Rating | Outperform | | N/A | |
| 4/28/2017 | Tigress Financial | Initiated Coverage | Neutral -> Neutral | | Low | |
| 4/22/2017 | Barclays PLC | Reiterated Rating | Overweight | $88.00 -> $82.00 | Low | |
| 4/21/2017 | Leerink Swann | Set Price Target | Hold | $72.00 | Low | |
| 4/19/2017 | William Blair | Downgrade | Outperform -> Market Perform | | Low | |
| 1/3/2017 | Mizuho | Downgrade | Buy -> Neutral | $79.00 | N/A | |
| 10/10/2016 | Cleveland Research | Downgrade | Buy -> Neutral | | N/A | |
| 9/19/2016 | Bank of America Corporation | Reiterated Rating | Hold | $90.00 | N/A | |
| 9/16/2016 | Goldman Sachs Group, Inc. (The) | Downgrade | Buy -> Neutral | $90.00 -> $83.00 | N/A | |
| 9/12/2016 | Morgan Stanley | Reiterated Rating | Hold | $91.00 | N/A | |
| 8/4/2016 | Deutsche Bank AG | Boost Price Target | Hold | $83.00 -> $89.00 | N/A | |
| 8/3/2016 | Citigroup Inc. | Boost Price Target | Neutral | $87.00 -> $93.00 | N/A | |
| 6/20/2016 | FBR & Co | Reiterated Rating | Buy | | N/A | |
| 6/1/2016 | Raymond James Financial, Inc. | Downgrade | Outperform -> Market Perform | | N/A | |
| 4/18/2016 | Avondale Partners | Initiated Coverage | Outperform | $111.00 | N/A | |
(Data available from 10/20/2015 forward)
Earnings History for Cardinal Health (NYSE:CAH)Earnings History by Quarter for Cardinal Health (NYSE CAH)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/30/2017 | | $1.12 | | | | | N/A | |
| 8/2/2017 | Q4 2017 | $1.24 | $1.31 | $32.73 billion | $32.97 billion | View | Listen | |
| 5/1/2017 | Q3 2017 | $1.46 | $1.53 | $32.30 billion | $31.82 billion | View | Listen | |
| 2/7/2017 | Q217 | $1.23 | $1.34 | $33.63 billion | $33.10 billion | View | Listen | |
| 10/31/2016 | Q117 | $1.21 | $1.24 | $31.12 billion | $32.00 billion | View | Listen | |
| 8/2/2016 | Q416 | $1.13 | $1.14 | $31.06 billion | $31.40 billion | View | N/A | |
| 4/28/2016 | Q316 | $1.33 | $1.43 | $30.54 billion | $30.70 billion | View | Listen | |
| 2/1/2016 | Q216 | $1.26 | $1.30 | $29.23 billion | $31.40 billion | View | N/A | |
| 11/2/2015 | Q116 | $1.10 | $1.38 | $27.19 billion | $28.10 billion | View | N/A | |
| 7/30/2015 | Q415 | $0.99 | $1.00 | $26.05 billion | $27.50 billion | View | Listen | |
| 4/30/2015 | Q3 | $1.16 | $1.19 | $24.40 billion | $25.38 billion | View | N/A | |
| 1/29/2015 | Q215 | $1.11 | $1.20 | $23.43 billion | $25.50 billion | View | N/A | |
| 10/30/2014 | Q115 | $0.96 | $1.00 | $22.43 billion | $24.07 billion | View | N/A | |
| 8/4/2014 | Q414 | $0.81 | $0.83 | $21.88 billion | $2.90 billion | View | N/A | |
| 5/1/2014 | Q314 | $1.01 | $1.01 | $21.72 million | $21.40 million | View | N/A | |
| 1/31/2014 | Q214 | $0.84 | $0.79 | $20.74 billion | $22.20 billion | View | N/A | |
| 10/31/2013 | Q114 | $0.86 | $1.10 | $22.73 billion | $24.50 billion | View | N/A | |
| 8/1/2013 | Q4 2013 | $0.77 | $0.79 | $24.56 billion | $25.40 billion | View | N/A | |
| 5/2/2013 | Q3 2013 | $0.95 | $1.20 | $24.72 billion | $24.60 billion | View | N/A | |
| 2/5/2013 | Q2 2013 | $0.86 | $0.93 | $24.61 million | $22.75 million | View | N/A | |
| 10/30/2012 | Q113 | $0.79 | $0.81 | $26.33 million | $25.90 million | View | N/A | |
| 8/2/2012 | | $0.73 | $0.73 | | | View | N/A | |
| 5/3/2012 | | $0.88 | $0.94 | | | View | N/A | |
| 2/2/2012 | | $0.77 | $0.81 | | | View | N/A | |
| 10/27/2011 | | $0.72 | $0.73 | | | View | N/A | |
| 8/4/2011 | | $0.58 | $0.59 | | | View | N/A | |
| 4/28/2011 | | $0.69 | $0.75 | | | View | N/A | |
| 2/3/2011 | | $0.61 | $0.69 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Cardinal Health (NYSE:CAH)2017 EPS Consensus Estimate: $5.28
2018 EPS Consensus Estimate: $5.03
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $1.21 | $1.26 | $1.23 |
| Q2 2017 | 3 | $1.20 | $1.33 | $1.26 |
| Q3 2017 | 3 | $1.43 | $1.60 | $1.50 |
| Q4 2017 | 4 | $1.24 | $1.41 | $1.29 |
| Q1 2018 | 3 | $0.99 | $1.18 | $1.08 |
| Q2 2018 | 3 | $1.13 | $1.34 | $1.23 |
| Q3 2018 | 3 | $1.41 | $1.55 | $1.46 |
| Q4 2018 | 3 | $1.20 | $1.30 | $1.27 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Cardinal Health (NYSE:CAH)| Most Recent Dividend: | 10/15/2017 |
| Annual Dividend: | $1.85 |
| Dividend Yield: | 2.77% |
| Dividend Growth: | 13.10% (3 Year Average) |
| Payout Ratio: | 45.79% (Trailing 12 Months of Earnings)
37.37% (Based on This Year's Estimates)
33.45% (Based on Next Year's Estimates)
|
| Track Record: | 12 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Cardinal Health (NYSE CAH)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 8/9/2017 | quarterly | $0.46 | 2.75% | 9/29/2017 | 10/2/2017 | 10/15/2017 |
| 5/3/2017 | quarterly | $0.46 | 2.54% | 6/29/2017 | 7/3/2017 | 7/15/2017 |
| 2/2/2017 | quarterly | $0.45 | 2.4% | 3/30/2017 | 4/3/2017 | 4/15/2017 |
| 11/3/2016 | quarterly | $0.45 | 2.76% | 12/29/2016 | 1/3/2017 | 1/15/2017 |
| 8/8/2016 | quarterly | $0.45 | 2.14% | 9/29/2016 | 10/3/2016 | 10/15/2016 |
| 5/4/2016 | quarterly | $0.45 | 2.29% | 6/29/2016 | 7/1/2016 | 7/15/2016 |
| 2/2/2016 | quarterly | $0.39 | 2% | 3/30/2016 | 4/1/2016 | 4/15/2016 |
| 11/4/2015 | quarterly | $0.39 | 1.76% | 12/30/2015 | 1/4/2016 | 1/15/2016 |
| 8/5/2015 | quarterly | $0.39 | 1.83% | 9/29/2015 | 10/1/2015 | 10/15/2015 |
| 5/6/2015 | quarterly | $0.39 | 1.82% | 6/29/2015 | 7/1/2015 | 7/15/2015 |
| 2/3/2015 | quarterly | $0.34 | 1.62% | 3/30/2015 | 4/1/2015 | 4/15/2015 |
| 11/5/2014 | quarterly | $0.34 | 1.72% | 12/30/2014 | 1/2/2015 | 1/15/2015 |
| 8/6/2014 | quarterly | $0.34 | 1.96% | 9/29/2014 | 10/1/2014 | 10/15/2014 |
| 5/7/2014 | quarterly | $0.34 | 2.14% | 6/27/2014 | 7/1/2014 | 7/15/2014 |
| 2/5/2014 | quarterly | $0.30 | 1.83% | 3/28/2014 | 4/1/2014 | 4/15/2014 |
| 11/6/2013 | quarterly | $0.30 | 1.99% | 12/30/2013 | 1/2/2014 | 1/15/2014 |
| 8/7/2013 | quarterly | $0.30 | 2.35% | 9/27/2013 | 10/1/2013 | 10/15/2013 |
| 5/2/2013 | quarterly | $0.30 | 2.61% | 6/27/2013 | 7/1/2013 | 7/15/2013 |
| 2/6/2013 | quarterly | $0.28 | 2.46% | 3/27/2013 | 4/1/2013 | 4/15/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Cardinal Health (NYSE:CAH)Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 87.88%
Insider Trades by Quarter for Cardinal Health (NYSE:CAH)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/12/2017 | Jon L Giacomin | CEO of Cardinal Health's pharmaceutical segment | Sell | 23,270 | $72.87 | $1,695,684.90 | |
| 2/10/2017 | George S Barrett | Chairman | Sell | 217,994 | $77.23 | $16,835,676.62 | |
| 11/10/2016 | George S Barrett | Chairman | Sell | 217,995 | $71.29 | $15,540,863.55 | |
| 8/18/2016 | Patricia Morrison | Insider | Sell | 43,959 | $82.50 | $3,626,617.50 | |
| 8/18/2016 | Stuart G Laws | SVP | Sell | 9,703 | $82.45 | $800,012.35 | |
| 8/16/2016 | Jon L Giacomin | CEO | Sell | 47,251 | $82.77 | $3,910,965.27 | |
| 8/11/2016 | Craig S Morford | Insider | Sell | 12,697 | $83.13 | $1,055,501.61 | |
| 8/10/2016 | Donald M Jr. Casey | CEO | Sell | 59,180 | $83.59 | $4,946,856.20 | |
| 8/10/2016 | George S Barrett | Chairman | Sell | 250,000 | $83.63 | $20,907,500.00 | |
| 8/9/2016 | George S Barrett | CEO | Sell | 129,818 | $83.76 | $10,873,555.68 | |
| 8/8/2016 | George S Barrett | CEO | Sell | 20,428 | $83.75 | $1,710,845.00 | |
| 5/20/2016 | Carole S Watkins | Insider | Sell | 84,617 | $77.33 | $6,543,432.61 | |
| 11/6/2015 | Falk T. Stephen | EVP | Sell | 30,085 | $87.66 | $2,637,251.10 | |
| 8/20/2015 | George S. Barrett | CEO | Sell | 300,000 | $83.08 | $24,924,000.00 | |
| 5/12/2015 | Falk T Stephen | EVP | Sell | 39,428 | $86.12 | $3,395,539.36 | |
| 5/11/2015 | George S Barrett | CEO | Sell | 300,000 | $86.44 | $25,932,000.00 | |
| 3/4/2015 | Colleen F Arnold | Director | Sell | 9,801 | $87.65 | $859,057.65 | |
| 3/3/2015 | Richard C Notebaert | Director | Sell | 9,801 | $88.20 | $864,448.20 | |
| 2/20/2015 | Carole S Watkins | Insider | Sell | 33,847 | $87.00 | $2,944,689.00 | |
| 2/10/2015 | Carole S Watkins | Insider | Sell | 50,770 | $85.00 | $4,315,450.00 | |
| 2/10/2015 | George S Barrett | CEO | Sell | 300,000 | $84.87 | $25,461,000.00 | |
| 11/7/2014 | Mark R Blake | EVP | Sell | 24,668 | $79.50 | $1,961,106.00 | |
| 9/5/2014 | Carole S Watkins | Insider | Sell | 40,794 | $75.00 | $3,059,550.00 | |
| 9/4/2014 | Michael C Kaufmann | CEO | Sell | 50,216 | $74.95 | $3,763,689.20 | |
| 8/27/2014 | Jeffrey William Henderson | CFO | Sell | 26,567 | $72.63 | $1,929,561.21 | |
| 8/18/2014 | Jeffrey William Henderson | CFO | Sell | 78,637 | $72.06 | $5,666,582.22 | |
| 8/18/2014 | Mark R Blake | EVP | Sell | 4,782 | $72.15 | $345,021.30 | |
| 8/18/2014 | Michael C Kaufmann | CEO | Sell | 6,833 | $72.06 | $492,385.98 | |
| 8/8/2014 | Craig S Morford | Insider | Sell | 43,359 | $70.03 | $3,036,430.77 | |
| 8/8/2014 | Jeffrey William Henderson | CFO | Sell | 118,093 | $69.72 | $8,233,443.96 | |
| 7/24/2014 | Mark R Blake | EVP | Sell | 23,114 | $73.41 | $1,696,798.74 | |
| 7/24/2014 | Stuart G Laws | CAO | Sell | 21,266 | $72.50 | $1,541,785.00 | |
| 7/14/2014 | Jeffrey William Henderson | CFO | Sell | 23,632 | $70.65 | $1,669,600.80 | |
| 5/19/2014 | Mark Blake | EVP | Sell | 4,703 | $66.50 | $312,749.50 | |
| 5/13/2014 | Mark Blake | EVP | Sell | 2,822 | $66.50 | $187,663.00 | |
| 5/7/2014 | Jeffrey William Henderson | CFO | Sell | 27,031 | $63.83 | $1,725,388.73 | |
| 2/11/2014 | Mark Blake | EVP | Sell | 2,330 | $68.53 | $159,674.90 | |
| 2/11/2014 | Michael Kaufmann | CEO | Sell | 388,995 | $67.46 | $26,241,602.70 | |
| 2/10/2014 | George Barrett | CEO | Sell | 200,000 | $66.64 | $13,328,000.00 | |
| 2/5/2014 | Gregory Kenny | Director | Sell | 18,175 | $65.39 | $1,188,463.25 | |
| 2/4/2014 | Carole Watkins | Insider | Sell | 46,666 | $65.71 | $3,066,422.86 | |
| 2/4/2014 | Falk Stephen | EVP | Sell | 17,926 | $65.56 | $1,175,228.56 | |
| 2/4/2014 | Richard Notebaert | Director | Sell | 10,727 | $65.68 | $704,549.36 | |
| 11/11/2013 | George Barrett | CEO | Sell | 200,000 | $62.71 | $12,542,000.00 | |
| 9/11/2013 | Mark R Blake | EVP | Sell | 14,584 | $51.53 | $751,513.52 | |
| 8/19/2013 | Mark Blake | EVP | Sell | 4,925 | $51.27 | $252,504.75 | |
| 8/16/2013 | Falk Stephen | EVP | Sell | 10,000 | $51.50 | $515,000.00 | |
| 8/15/2013 | Craig Morford | Insider | Sell | 20,000 | $51.33 | $1,026,600.00 | |
| 8/13/2013 | George Barrett | CEO | Sell | 75,000 | $52.09 | $3,906,750.00 | |
| 8/13/2013 | Jeffrey William Henderson | CFO | Sell | 54,590 | $51.99 | $2,838,134.10 | |
| 8/8/2013 | Calvin Darden | Director | Sell | 3,254 | $51.48 | $167,515.92 | |
| 8/5/2013 | Mark Blake | EVP | Sell | 29,166 | $51.53 | $1,502,923.98 | |
| 7/26/2013 | Jeffrey William Henderson | CFO | Sell | 76,781 | $50.99 | $3,915,063.19 | |
| 7/18/2013 | Jeffrey William Henderson | CFO | Sell | 57,623 | $49.99 | $2,880,573.77 | |
| 7/15/2013 | Jeffrey William Henderson | CFO | Sell | 14,660 | $49.99 | $732,853.40 | |
| 7/11/2013 | Jeffrey William Henderson | CFO | Sell | 83,211 | $48.99 | $4,076,506.89 | |
| 6/19/2013 | John F Finn | Director | Sell | 11,070 | $48.51 | $537,005.70 | |
| 5/28/2013 | Jean G Spaulding | Director | Sell | 8,350 | $47.35 | $395,372.50 | |
| 5/22/2013 | Richard C Notebaert | Director | Sell | 3,197 | $48.10 | $153,775.70 | |
| 5/20/2013 | Carole S Watkins | Insider | Sell | 4,612 | $48.00 | $221,376.00 | |
| 5/20/2013 | Jean G Spaulding | Director | Sell | 1,666 | $47.90 | $79,801.40 | |
| 11/1/2012 | Stuart G Laws | CAO | Sell | 2,564 | $41.22 | $105,688.08 | |
| 10/4/2012 | Jeffrey William Henderson | CFO | Sell | 46,226 | $40.00 | $1,849,040.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Cardinal Health (NYSE:CAH)
Latest Headlines for Cardinal Health (NYSE:CAH)
| Source: |
|
| Date | Headline |
|---|
 | See what the IHS Markit Score report has to say about Cardinal Health Inc.
finance.yahoo.com - October 19 at 4:17 AM |
| Shanghai Pharma bids for U.S. Cardinal Health's China business
finance.yahoo.com - October 18 at 6:11 PM |
 | Industry Group Rank Analysis Makes Cardinal Health (CAH) a Strong Sell
investorplace.com - October 18 at 5:17 PM |
| Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2018 on November 6
finance.yahoo.com - October 17 at 5:41 PM |
 | Cardinal Health, distributors respond to Washington Post/60 Minutes opioid investigation - Columbus Business First
www.bizjournals.com - October 16 at 10:46 PM |
| Cardinal Health, Inc. : CAH-US: Dividend Analysis : October 02nd, 2017 (record date) : By the numbers : October 16, 2017
finance.yahoo.com - October 16 at 5:44 PM |
| 7 Stocks To Watch Ahead Of The 60 Minutes DEA-Opioid Exposé
finance.yahoo.com - October 13 at 5:31 PM |
 | Cardinal Health, Inc. (CAH) Stock Rating Reaffirmed by Needham & Company LLC
www.americanbankingnews.com - October 12 at 12:40 PM |
| Cardinal Health competitor – and Dublin neighbor – gains clout in acquisition by larger company
www.bizjournals.com - October 11 at 6:21 PM |
| How Shanghai Pharma Can Get High
finance.yahoo.com - October 9 at 10:38 PM |
 | You Should Not Miss Cardinal Health In 2017
seekingalpha.com - October 9 at 5:37 PM |
| Cardinal's China Exit Pits PE Against State Firm
finance.yahoo.com - October 9 at 5:37 PM |
| Cardinal Health (CAH) Stock Upgraded to Sell - Investorplace.com
investorplace.com - October 7 at 3:22 AM |
| Robust Growth Expected for Cardinal Health’s Specialty Solutions
finance.yahoo.com - October 6 at 5:11 PM |
| Patient Recovery Acquisition May Boost Cardinal Health’s Revenues
finance.yahoo.com - October 6 at 5:11 PM |
| Cardinal Health Expected to Report Modest Revenue Growth
finance.yahoo.com - October 5 at 8:53 PM |
| Cardinal Health: Stable Net Profit Margins in Fiscal 2018?
finance.yahoo.com - October 5 at 8:53 PM |
| Analyst Recommendations for Cardinal Health and Peers in October
finance.yahoo.com - October 5 at 3:51 PM |
| Cardinal Health, Inc. (CAH) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 4 at 8:44 PM |
| $33.41 Billion in Sales Expected for Cardinal Health, Inc. (CAH) This Quarter
www.americanbankingnews.com - October 4 at 9:42 AM |
| Big Pharma Is Getting Hit With a Huge Wave of Opioid Suits
finance.yahoo.com - October 2 at 3:08 PM |
 | Ex-Dividend Reminder: Cardinal Health, Raymond James Financial and CubeSmart
www.nasdaq.com - September 27 at 5:41 PM |
| Cardinal Health: A Dividend Aristocrat Trading Near Its All-Time High Yield - Seeking Alpha
seekingalpha.com - September 20 at 10:42 PM |
| Cardinal Health, Inc. (CAH) Research Coverage Started at Royal Bank Of Canada
www.americanbankingnews.com - September 19 at 7:38 AM |
| Cardinal Health, Inc. (CAH) Stock Rating Reaffirmed by Robert W. Baird
www.americanbankingnews.com - September 17 at 7:42 AM |
| How Safe Is Cardinal Health's Dividend?
finance.yahoo.com - September 15 at 5:18 PM |
 | How Safe Is Cardinal Health's Dividend?
www.fool.com - September 15 at 8:16 AM |
| Analysts Anticipate Cardinal Health, Inc. (CAH) Will Announce Quarterly Sales of $33.44 Billion
www.americanbankingnews.com - September 15 at 3:18 AM |
| Analysts Anticipate Cardinal Health, Inc. (CAH) Will Announce Earnings of $1.01 Per Share
www.americanbankingnews.com - September 14 at 12:24 AM |
| Cardinal Health (CAH) and Prestige Brand Holdings (PBH) Critical Analysis
www.americanbankingnews.com - September 11 at 10:32 PM |
| Needham & Company LLC Reaffirms Hold Rating for Cardinal Health, Inc. (CAH)
www.americanbankingnews.com - September 11 at 8:24 PM |
| Cardinal Health, Inc. (CAH) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 9 at 4:48 PM |
| Why Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - September 9 at 3:21 AM |
| Why Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report?
finance.yahoo.com - September 8 at 5:16 PM |
| 4 Top MedTech Stocks for Dividend Investors in 2017
finance.yahoo.com - September 8 at 5:16 PM |
| New Mexico sues opioid drug manufacturers, distributors
finance.yahoo.com - September 7 at 4:37 PM |
| Head-To-Head Review: Prestige Brand Holdings (PBH) and Cardinal Health (CAH)
www.americanbankingnews.com - September 4 at 2:12 PM |
| Recent Buy: Cardinal Health Inc.
seekingalpha.com - August 31 at 4:46 PM |
| Cardinal Health Becomes Oversold - Nasdaq
www.nasdaq.com - August 30 at 6:13 PM |
| Cardinal Health, Inc. (CAH) Given a $77.00 Price Target by Jefferies Group LLC Analysts
www.americanbankingnews.com - August 29 at 9:28 PM |
| Bert's Recent Buy - Cardinal Health
seekingalpha.com - August 24 at 4:58 PM |
| ETFs with exposure to Cardinal Health, Inc. : August 24, 2017
finance.yahoo.com - August 24 at 4:57 PM |
| Dividend Yield of Cardinal Health
finance.yahoo.com - August 23 at 5:04 PM |
 | Cardinal Health: Cramer's Top Takeaways - TheStreet.com
www.thestreet.com - August 22 at 10:34 PM |
| Cardinal Health, Inc. :CAH-US: Earnings Analysis: Q4, 2017 By the Numbers : August 21, 2017
finance.yahoo.com - August 22 at 10:34 PM |
| Cramer Remix: Why these US oil fields may be about to make a big market impact
finance.yahoo.com - August 22 at 10:34 PM |
| Cramer Remix: Why these US oil fields may be about to mak...
finance.yahoo.com - August 22 at 10:34 PM |
| Cardinal Health: Cramer's Top Takeaways
finance.yahoo.com - August 22 at 10:34 PM |
| Drug Distributors: Bear Vs. Bull Debate
finance.yahoo.com - August 21 at 4:48 PM |
| Cardinal Health, Inc. : CAH-US: Dividend Analysis : July 03rd, 2017 (record date) : By the numbers : August 16, 2017
finance.yahoo.com - August 16 at 5:24 PM |
Cardinal Health (CAH) Chart for Friday, October, 20, 2017
